Duke Health hosted leaders from the U.S. Department of Health and Human Services, Microsoft, and UNC-Chapel Hill, to talk about next steps in making trustworthy health care artificial intelligence (AI) a reality.  

Resilience, flexibility and the courage to take on new challenges. Those were three key attributes the Class of 2024 was lauded for during their Graduation and Hooding Ceremony held at The Ngee Ann Kongsi Auditorium on Saturday, 1 June.

Drs. Cathleen Colón-Emeric, Loretta Que and Heather Whitson were selected as a members of the 2024-2025 class of fellows for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program at Drexel University College of Medicine.

Michael Boyce, PhD, Associate Professor of Biochemistry and co-director of the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) program, a national program to enhance faculty diversity at research universities, organized by the American Society for Cell Biology (ASCB) and funded by National Institutes of Health (NIH).

Anthony S. Fauci, MD, visited Duke at the invitation of Bart Haynes, MD, Frederic M. Hanes Distinguished Professor of Medicine and director of the Duke Human Vaccine Institute (DHVI). He took the audience on a journey though time spanning his 58-year medical career.

Four staff members from across the School of Medicine have been named recipients of the Dean’s Staff Awards for 2024. The Dean’s Staff Awards are presented annually to recognize exemplary staff supporting the School of Medicine’s mission and values.  

Intervening to reduce alcohol use is associated with a lower likelihood that an individual will receive a new opioid prescription or develop an opioid use disorder, according to a study led by researchers at Duke University and the Durham Veterans Affairs (VA) Medical Center.

Globally, the need for mental health care far outstrips the number of professionally trained providers. Duke global health researchers and clinicians are helping address that need by training non-specialists to provide mental health support in communities without access to specialized resources.

Dr. Klotman shares news about faculty awards, graduation and more.

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.